S&P 500
5,949.20
-0.2%
-14.40
DJI
42,707.44
-0.2%
-84.63
NASDAQ
$19,178.87
-0.2%
-$36.59
Bitcoin
105,326.00
+0.1%
+126.75
AAPL
$207.35
-0.7%
-$1.43
AMZN
$203.90
-1.1%
-$2.26
GOOG
$169.00
+0.7%
+$1.13
META
$638.07
-0.4%
-$2.36
MSFT
$457.26
-0.4%
-$1.61
NVDA
$134.10
-1.1%
-$1.47
TSLA
$351.05
+2.6%
+$8.96
Vaxcyte (NASDAQ: PCVX)
$33.83
(5.6%)
$1.80
Price as of May 20, 2025, 1:14 p.m. ET
Vaxcyte Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Vaxcyte Company Info
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering, and Jeff Fairman on November 27, 2013 and is headquartered in San Carlos, CA.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.